UNSPSC 51121914: Bemarinone

This classification denotes a cardiotonic agent with the molecular formula C11H12N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 29J330V3XV, chemically known as 2(1h)-quinazolinone, 5,6-dimethoxy-4-methyl- but generally known as bemarinone, which bears US NIH Compound Identifier 58575. Bemarinone most often comes in base and hydrochloride forms. European Medicines Agency schedules Bemarinone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05690MIG.

UNSPSC 51121914 Bemarinone is a Commodity code covering pharmaceutical products procured by state and local government agencies for emergency medical services, pharmacy benefit programs, and health service operations. State and local governments buy specific emergency life-support medications, generic multi-source pharmaceuticals, and over-the-counter products under this code, typically through sealed competitive bidding, cooperative purchasing agreements, and requests for proposal that establish volume commitments and pricing terms with manufacturers and authorized wholesalers. Issuing bodies include municipal fire and rescue services, state health and human services departments, and multistate cooperative purchasing alliances that aggregate demand across participating jurisdictions. Recent solicitations reflect two distinct buying patterns: immediate-need procurement for specific medication line items (such as emergency cardiac and vasopressor drugs for first-responder use) and longer-term framework agreements that establish pricing and supply relationships for generic pharmaceuticals distributed through authorized wholesale channels.

Recent activity spans Florida, Texas, and Minnesota-led cooperative procurement. The City of Tampa's Purchasing Department issued an IFB (Solicitation 26P00188) on April 24, 2026, for Advanced Life Support Medications (four specific drugs totaling approximately 3,530 units for Tampa Fire Rescue) with a response deadline of April 8, 2026 and estimated contract value of $40,000, featuring a 5 percent Small Local Business Enterprise bid discount. The Texas Health and Human Services Commission posted an RFI (HHS0017013) on April 3, 2026, seeking vendor capabilities for a Direct-to-Manufacturer Prescriptions program outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by Minnesota's Department of Administration Office of State Procurement, issued an RFP (S1070000015802) with a March 26, 2026, response deadline for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities, requiring vendors to supply through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson) with contract effectiveness on July 1, 2026, and evaluation weighted 75 percent on price competitiveness.